RYAN STITZLEIN

A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Access to evidence-based medication abortion care; Anti-abortion centers/crisis pregnancy centers, including H.R.10356 the Empowering Moms Act; Administrative actions that restrict contraceptive access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions.

The link between immigrant justice and reproductive reproductive freedom; H.R.4104 and S.2149, the Health Equity & Access under the Law (HEAL) for Immigrant Families Act, which would remove political interference and restore coverage so immigrants in the United States could participate in the health insurance programs for which they would be eligible but for their immigration status or length of stay.

The link between immigrant justice and reproductive reproductive freedom; H.R.4104 and S.2149, the Health Equity & Access under the Law (HEAL) for Immigrant Families Act, which would remove political interference and restore coverage so immigrants in the United States could participate in the health insurance programs for which they would be eligible but for their immigration status or length of stay.

A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Access to evidence-based medication abortion care; Anti-abortion centers/crisis pregnancy centers, including H.R.10356 the Empowering Moms Act; Administrative actions that restrict contraceptive access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The link between immigrant justice and reproductive reproductive freedom; H.R.4104 and S.2149, the Health Equity & Access under the Law (HEAL) for Immigrant Families Act, which would remove political interference and restore coverage so immigrants in the United States could participate in the health insurance programs for which they would be eligible but for their immigration status or length of stay.

The link between immigrant justice and reproductive reproductive freedom; H.R.4104 and S.2149, the Health Equity & Access under the Law (HEAL) for Immigrant Families Act, which would remove political interference and restore coverage so immigrants in the United States could participate in the health insurance programs for which they would be eligible but for their immigration status or length of stay.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Access to evidence-based medication abortion care; Anti-abortion centers/crisis pregnancy centers, including H.R.10356 the Empowering Moms Act; Administrative actions that restrict contraceptive access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.Con.Res.78 and S.Con.Res.28, Abortion Provider Appreciation Day Resolution; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits and health savings accounts; Extension of ACA enhanced premium tax credits; Access to evidence-based medication abortion care; Veterans access to reproductive health care, including H.R.4876, the Reproductive Freedom for Veterans Act; Funding for anti-abortion centers/crisis pregnancy centers, including H.R.6945, the Supporting Pregnant and Parenting Women and Families Act and in appropriations bills; H.R.6359 and S.3627, the Pregnant Students Rights Act; Healthy pregnancy and postpartum period; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Attempts to weaken nondiscrimination protections for people with gender dysphoria, including Health and Human Services proposed Rule 0945-AA27 modifying 45 C.F.R. Part 84, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; H.Res.1058 and S.Res.604, the Transgender Bill of Rights; H.Con.Res.82 and S.Con.Res.32, supporting the goals and ideals of International Transgender Day of Visibility; Bans and restrictions on gender affirming care; Proposed rule, RIN 0938-AV87 modifying 42 C.F.R. Part 482, that would bar hospitals from participating in Medicare and Medicaid if they provide transition-related health care (TRH); Proposed rule, RIN 0938-AV73 modifying 42 C.F.R. Parts 441 and 457, that would prohibit Medicaid and Childrens Health Insurance Program (CHIP) funding for transition-related health care (TRH); Issues related to workplace fairness and gender discrimination; the Equal Employment Opportunity Commissions (EEOC) proposed rescission of its Enforcement Guidance on Workplace Harassment.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

FY26 appropriations for Departments of Labor, Health and Human Services, and Education, and related agencies, including the Hyde amendment, the Weldon amendment, increased funding for Title X, zeroing out abstinence-only education, increasing funding for the Teen Pregnancy Prevention Program, funding for entities that offer abortion care, and abortion-related executive orders; FY26 appropriations for National Security, Department of State, and Related Programs, including the Helms amendment, the Hyde amendment, increased funding for international family planning and reproductive health programs, increased funding for UNFPA, ending the Kemp-Kasten amendment, and the Livingston amendment; FY26 appropriations for Military Construction, Veterans Affairs, and Related Agencies, including veterans access to abortion services; FY26 appropriations for Department of Agriculture, Rural Development, Food and Drug Administration, including FDA approval of mifepristone; FY26 appropriations for Department of Defense, including access to abortion services and gender affirming care for servicemembers and their dependents; FY26 appropriations for Financial Services and General Government, including reproductive freedom attacks aimed at the District of Columbia, bans on abortion coverage for federal employees, denials of coverage for contraceptive care and supplies; FY26 appropriations for Commerce, Justice, Science, and Related Agencies, including bans on abortion for people in federal prison; Poison pill riders in FY26 appropriations bills; Funding cuts to Medicaid and other essential services that families rely on to make ends meet; H.Con.Res.14, H.R. 1 FY25 Budget Reconciliation.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; H.R.21 and S.6, the so-called Born-Alive Abortion Survivors Protection Act; Grants to enhance security and safety for health care providers, including H.R.612, the Health Care Providers Safety Act; Data and health records privacy as it relates to abortion care; Issues related to emergency abortion care, including Idaho v. United States; Issues Medina v. Planned Parenthood South Atlantic (PPSAT) and Medicaids free-choice-of-provider provision; Funding for costs related to traveling for abortion care; Access to evidence-based medication abortion care; Issues related to the Comstock Act, including H.R.2029 and S.951, the Stop Comstock Act; Access to and affordability of contraceptives; Access to contraception and the right to contraception, including H.R.999 and S.422 the Right to Contraception Act; Contraceptive coverage, including H.R.2529 and S.1239, requiring insurers to cover a full year supply of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including H.R.1742, the Access to Reproductive Care for Servicemembers Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including breastfeeding support; S.916 Stop Shackling and Detaining Pregnant Women Act; Paid Family and Medical Leave, including H.R. 1035 and S.408, the Job Protection Act and H.R.1002 and S.437, the Caring for All Families Act; Child tax credit and using the tax code to increase investments in women and families; Foreign aid and investments in international family planning; Gender equity and sex discrimination, including H.R.17 and S.1115, the Paycheck Fairness Act; LGBTQI+ rights; Discrimination against LGBTQI+ people, including the joint resolution H.Con.Res.23 and S.Con.Res.11, Supporting the goals and ideals of International Transgender Day of Visibility; H.R.28 and S.9, Protection of Women and Girls in Sports Act of 2025; Bans and restrictions on gender affirming care.

FY26 appropriations for Departments of Labor, Health and Human Services, and Education, and related agencies, including the Hyde amendment, the Weldon amendment, increased funding for Title X, zeroing out abstinence-only education, increasing funding for the Teen Pregnancy Prevention Program, funding for entities that offer abortion care, and abortion-related executive orders; FY26 appropriations for National Security, Department of State, and Related Programs, including the Helms amendment, the Hyde amendment, increased funding for international family planning and reproductive health programs, increased funding for UNFPA, ending the Kemp-Kasten amendment, and the Livingston amendment; FY26 appropriations for Military Construction, Veterans Affairs, and Related Agencies, including veterans access to abortion services; FY26 appropriations for Department of Agriculture, Rural Development, Food and Drug Administration, including FDA approval of mifepristone; FY26 appropriations for Department of Defense, including access to abortion services and gender affirming care for servicemembers and their dependents; FY26 appropriations for Financial Services and General Government, including reproductive freedom attacks aimed at the District of Columbia, bans on abortion coverage for federal employees, denials of coverage for contraceptive care and supplies; FY26 appropriations for Commerce, Justice, Science, and Related Agencies, including bans on abortion for people in federal prison; Poison pill riders in FY26 appropriations bills; Funding cuts to Medicaid and other essential services that families rely on to make ends meet; H.Con.Res.14, H.R. 1 FY25 Budget Reconciliation.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; H.R.21 and S.6, the so-called Born-Alive Abortion Survivors Protection Act; Grants to enhance security and safety for health care providers, including H.R.612, the Health Care Providers Safety Act; Data and health records privacy as it relates to abortion care; Issues related to emergency abortion care, including Idaho v. United States; Issues Medina v. Planned Parenthood South Atlantic (PPSAT) and Medicaids free-choice-of-provider provision; Funding for costs related to traveling for abortion care; Access to evidence-based medication abortion care; Issues related to the Comstock Act, including H.R.2029 and S.951, the Stop Comstock Act; Access to and affordability of contraceptives; Access to contraception and the right to contraception, including H.R.999 and S.422 the Right to Contraception Act; Contraceptive coverage, including H.R.2529 and S.1239, requiring insurers to cover a full year supply of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including H.R.1742, the Access to Reproductive Care for Servicemembers Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including breastfeeding support; S.916 Stop Shackling and Detaining Pregnant Women Act; Paid Family and Medical Leave, including H.R. 1035 and S.408, the Job Protection Act and H.R.1002 and S.437, the Caring for All Families Act; Child tax credit and using the tax code to increase investments in women and families; Foreign aid and investments in international family planning; Gender equity and sex discrimination, including H.R.17 and S.1115, the Paycheck Fairness Act; LGBTQI+ rights; Discrimination against LGBTQI+ people, including the joint resolution H.Con.Res.23 and S.Con.Res.11, Supporting the goals and ideals of International Transgender Day of Visibility; H.R.28 and S.9, Protection of Women and Girls in Sports Act of 2025; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; H.R.21 and S.6, the so-called Born-Alive Abortion Survivors Protection Act; Grants to enhance security and safety for health care providers, including H.R.612, the Health Care Providers Safety Act; Data and health records privacy as it relates to abortion care; Issues related to emergency abortion care, including Idaho v. United States; Issues Medina v. Planned Parenthood South Atlantic (PPSAT) and Medicaids free-choice-of-provider provision; Funding for costs related to traveling for abortion care; Access to evidence-based medication abortion care; Issues related to the Comstock Act, including H.R.2029 and S.951, the Stop Comstock Act; Access to and affordability of contraceptives; Access to contraception and the right to contraception, including H.R.999 and S.422 the Right to Contraception Act; Contraceptive coverage, including H.R.2529 and S.1239, requiring insurers to cover a full year supply of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including H.R.1742, the Access to Reproductive Care for Servicemembers Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including breastfeeding support; S.916 Stop Shackling and Detaining Pregnant Women Act; Paid Family and Medical Leave, including H.R. 1035 and S.408, the Job Protection Act and H.R.1002 and S.437, the Caring for All Families Act; Child tax credit and using the tax code to increase investments in women and families; Foreign aid and investments in international family planning; Gender equity and sex discrimination, including H.R.17 and S.1115, the Paycheck Fairness Act; LGBTQI+ rights; Discrimination against LGBTQI+ people, including the joint resolution H.Con.Res.23 and S.Con.Res.11, Supporting the goals and ideals of International Transgender Day of Visibility; H.R.28 and S.9, Protection of Women and Girls in Sports Act of 2025; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; H.R.12 and S.2150, the Women's Health Protection Act of 2025, regarding access to abortion care; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Abortion-coverage restrictions; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services and H.R.589, the FACE Act Repeal Act of 2025; Data and health records privacy as it relates to abortion care, including H.R.3916 and S.2029, the My Body, My Data Act; Issues related to emergency abortion care; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R.4099, Ensuring Womens Right to Reproductive Freedom Act, regarding the right to travel to seek reproductive health care; Access to evidence-based medication abortion care; Access to and affordability of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including the Reproductive Freedom for Veterans Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including Medicaid coverage and access to labor and delivery units; Maternal and child health funding, including Title V and SET-NET; Empowering and informing young people about sexual and reproductive health, including H.R.3527 and S.1910, the Real Education and Access for Healthy Youth Act (REAHYA), which would provide federal funding for comprehensive sex education and H.Res.445 Sex Ed for All Month: Equity and Access for All Resolution; Paid Family and Medical Leave; Continued operation of the Labor Departments Womens Bureau; Continued operation of the Department of Education; Foreign aid and investments in international family planning; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; H.R.21 and S.6, the so-called Born-Alive Abortion Survivors Protection Act; Grants to enhance security and safety for health care providers, including H.R.612, the Health Care Providers Safety Act; Data and health records privacy as it relates to abortion care; Issues related to emergency abortion care, including Idaho v. United States; Issues Medina v. Planned Parenthood South Atlantic (PPSAT) and Medicaids free-choice-of-provider provision; Funding for costs related to traveling for abortion care; Access to evidence-based medication abortion care; Issues related to the Comstock Act, including H.R.2029 and S.951, the Stop Comstock Act; Access to and affordability of contraceptives; Access to contraception and the right to contraception, including H.R.999 and S.422 the Right to Contraception Act; Contraceptive coverage, including H.R.2529 and S.1239, requiring insurers to cover a full year supply of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including H.R.1742, the Access to Reproductive Care for Servicemembers Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including breastfeeding support; S.916 Stop Shackling and Detaining Pregnant Women Act; Paid Family and Medical Leave, including H.R. 1035 and S.408, the Job Protection Act and H.R.1002 and S.437, the Caring for All Families Act; Child tax credit and using the tax code to increase investments in women and families; Foreign aid and investments in international family planning; Gender equity and sex discrimination, including H.R.17 and S.1115, the Paycheck Fairness Act; LGBTQI+ rights; Discrimination against LGBTQI+ people, including the joint resolution H.Con.Res.23 and S.Con.Res.11, Supporting the goals and ideals of International Transgender Day of Visibility; H.R.28 and S.9, Protection of Women and Girls in Sports Act of 2025; Bans and restrictions on gender affirming care.

Federal courts and judicial nominees; Support for the continued confirmation of judges committed to civil and human rights; Support for Supreme Court ethics reform, term limits and expansion; The Supreme Court Tenure Establishment and Retirement Modernization (TERM) Act; H.R.1702, and H.R.1929 the JUDGES Act, to authorize additional district judges for the district courts and convert temporary judgeships; Nomination of Pam Bondi to be Attorney General; Nomination of Harmeet Dhillon to be Assistant Attorney General for Civil Rights; Nomination of Dean John Sauer to be Solicitor General; Nomination of Aaron Reitz to be Director of the Office of Legal Policy; Nomination of Marco Rubio to be Secretary of State; Nomination of Robert Kennedy Jr. to be Secretary of Health and Human Services; Nomination of Mehmet Oz to be Director of the Centers for Medicare and Medicaid Services Administrator; Nomination of Martin Makary to be Director of the Food and Drug Administration; Nomination of Dave Weldon to be Director of the Centers for Disease Control and Prevention; Nomination of Elise Stefanik to be U.S. Ambassador to the United Nations; Nomination of Russ Vought to be Director of the Office of Management and Budget (OMB); Nomination of Doug Collins to be Secretary of Veterans Affairs; Nomination of Pete Hegseth to be Secretary of Defense.

Federal courts and judicial nominees; Support for confirmation of judges committed to civil and human rights; H.R.1702, the JUDGES Act, to authorize additional district judges for the district courts and convert temporary judgeships; Nomination of Harmeet Dhillon to be Assistant Attorney General for Civil Rights; Nomination of Dean John Sauer to be Solicitor General; Nomination of Mehmet Oz to be Director of the Centers for Medicare and Medicaid Services Administrator; Nomination of James ONeill to be Deputy Secretary of Health and Human Services; Nomination of T. Elliot Gaiser to be Assistant Attorney General for the Office of Legal Counsel (OLC) at the Department of Justice (DOJ); Nomination of Whitney Hermandorfer to the U.S. Court of Appeals for the Sixth Circuit; Nomination of Joshua Divine to the District Court Missouri; Nomination of Maria Lanahan to the Missouri District Court; Nomination of Jordan Pratt to the Middle District of Florida; Nomination of John Guard to the Middle District of Florida.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; H.R.21 and S.6, the so-called Born-Alive Abortion Survivors Protection Act; Grants to enhance security and safety for health care providers, including H.R.612, the Health Care Providers Safety Act; Data and health records privacy as it relates to abortion care; Issues related to emergency abortion care, including Idaho v. United States; Issues Medina v. Planned Parenthood South Atlantic (PPSAT) and Medicaids free-choice-of-provider provision; Funding for costs related to traveling for abortion care; Access to evidence-based medication abortion care; Issues related to the Comstock Act, including H.R.2029 and S.951, the Stop Comstock Act; Access to and affordability of contraceptives; Access to contraception and the right to contraception, including H.R.999 and S.422 the Right to Contraception Act; Contraceptive coverage, including H.R.2529 and S.1239, requiring insurers to cover a full year supply of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including H.R.1742, the Access to Reproductive Care for Servicemembers Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including breastfeeding support; S.916 Stop Shackling and Detaining Pregnant Women Act; Paid Family and Medical Leave, including H.R. 1035 and S.408, the Job Protection Act and H.R.1002 and S.437, the Caring for All Families Act; Child tax credit and using the tax code to increase investments in women and families; Foreign aid and investments in international family planning; Gender equity and sex discrimination, including H.R.17 and S.1115, the Paycheck Fairness Act; LGBTQI+ rights; Discrimination against LGBTQI+ people, including the joint resolution H.Con.Res.23 and S.Con.Res.11, Supporting the goals and ideals of International Transgender Day of Visibility; H.R.28 and S.9, Protection of Women and Girls in Sports Act of 2025; Bans and restrictions on gender affirming care.

Federal courts and judicial nominees; Support for the continued confirmation of judges committed to civil and human rights; Support for Supreme Court ethics reform, term limits and expansion; The Supreme Court Tenure Establishment and Retirement Modernization (TERM) Act; H.R.1702, and H.R.1929 the JUDGES Act, to authorize additional district judges for the district courts and convert temporary judgeships; Nomination of Pam Bondi to be Attorney General; Nomination of Harmeet Dhillon to be Assistant Attorney General for Civil Rights; Nomination of Dean John Sauer to be Solicitor General; Nomination of Aaron Reitz to be Director of the Office of Legal Policy; Nomination of Marco Rubio to be Secretary of State; Nomination of Robert Kennedy Jr. to be Secretary of Health and Human Services; Nomination of Mehmet Oz to be Director of the Centers for Medicare and Medicaid Services Administrator; Nomination of Martin Makary to be Director of the Food and Drug Administration; Nomination of Dave Weldon to be Director of the Centers for Disease Control and Prevention; Nomination of Elise Stefanik to be U.S. Ambassador to the United Nations; Nomination of Russ Vought to be Director of the Office of Management and Budget (OMB); Nomination of Doug Collins to be Secretary of Veterans Affairs; Nomination of Pete Hegseth to be Secretary of Defense.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; H.R.21 and S.6, the so-called Born-Alive Abortion Survivors Protection Act; Grants to enhance security and safety for health care providers, including H.R.612, the Health Care Providers Safety Act; Data and health records privacy as it relates to abortion care; Issues related to emergency abortion care, including Idaho v. United States; Issues Medina v. Planned Parenthood South Atlantic (PPSAT) and Medicaids free-choice-of-provider provision; Funding for costs related to traveling for abortion care; Access to evidence-based medication abortion care; Issues related to the Comstock Act, including H.R.2029 and S.951, the Stop Comstock Act; Access to and affordability of contraceptives; Access to contraception and the right to contraception, including H.R.999 and S.422 the Right to Contraception Act; Contraceptive coverage, including H.R.2529 and S.1239, requiring insurers to cover a full year supply of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including H.R.1742, the Access to Reproductive Care for Servicemembers Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including breastfeeding support; S.916 Stop Shackling and Detaining Pregnant Women Act; Paid Family and Medical Leave, including H.R. 1035 and S.408, the Job Protection Act and H.R.1002 and S.437, the Caring for All Families Act; Child tax credit and using the tax code to increase investments in women and families; Foreign aid and investments in international family planning; Gender equity and sex discrimination, including H.R.17 and S.1115, the Paycheck Fairness Act; LGBTQI+ rights; Discrimination against LGBTQI+ people, including the joint resolution H.Con.Res.23 and S.Con.Res.11, Supporting the goals and ideals of International Transgender Day of Visibility; H.R.28 and S.9, Protection of Women and Girls in Sports Act of 2025; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; H.R.21 and S.6, the so-called Born-Alive Abortion Survivors Protection Act; Grants to enhance security and safety for health care providers, including H.R.612, the Health Care Providers Safety Act; Data and health records privacy as it relates to abortion care; Issues related to emergency abortion care, including Idaho v. United States; Issues Medina v. Planned Parenthood South Atlantic (PPSAT) and Medicaids free-choice-of-provider provision; Funding for costs related to traveling for abortion care; Access to evidence-based medication abortion care; Issues related to the Comstock Act, including H.R.2029 and S.951, the Stop Comstock Act; Access to and affordability of contraceptives; Access to contraception and the right to contraception, including H.R.999 and S.422 the Right to Contraception Act; Contraceptive coverage, including H.R.2529 and S.1239, requiring insurers to cover a full year supply of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including H.R.1742, the Access to Reproductive Care for Servicemembers Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including breastfeeding support; S.916 Stop Shackling and Detaining Pregnant Women Act; Paid Family and Medical Leave, including H.R. 1035 and S.408, the Job Protection Act and H.R.1002 and S.437, the Caring for All Families Act; Child tax credit and using the tax code to increase investments in women and families; Foreign aid and investments in international family planning; Gender equity and sex discrimination, including H.R.17 and S.1115, the Paycheck Fairness Act; LGBTQI+ rights; Discrimination against LGBTQI+ people, including the joint resolution H.Con.Res.23 and S.Con.Res.11, Supporting the goals and ideals of International Transgender Day of Visibility; H.R.28 and S.9, Protection of Women and Girls in Sports Act of 2025; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; H.R.21 and S.6, the so-called Born-Alive Abortion Survivors Protection Act; Grants to enhance security and safety for health care providers, including H.R.612, the Health Care Providers Safety Act; Data and health records privacy as it relates to abortion care; Issues related to emergency abortion care, including Idaho v. United States; Issues Medina v. Planned Parenthood South Atlantic (PPSAT) and Medicaids free-choice-of-provider provision; Funding for costs related to traveling for abortion care; Access to evidence-based medication abortion care; Issues related to the Comstock Act, including H.R.2029 and S.951, the Stop Comstock Act; Access to and affordability of contraceptives; Access to contraception and the right to contraception, including H.R.999 and S.422 the Right to Contraception Act; Contraceptive coverage, including H.R.2529 and S.1239, requiring insurers to cover a full year supply of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including H.R.1742, the Access to Reproductive Care for Servicemembers Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including breastfeeding support; S.916 Stop Shackling and Detaining Pregnant Women Act; Paid Family and Medical Leave, including H.R. 1035 and S.408, the Job Protection Act and H.R.1002 and S.437, the Caring for All Families Act; Child tax credit and using the tax code to increase investments in women and families; Foreign aid and investments in international family planning; Gender equity and sex discrimination, including H.R.17 and S.1115, the Paycheck Fairness Act; LGBTQI+ rights; Discrimination against LGBTQI+ people, including the joint resolution H.Con.Res.23 and S.Con.Res.11, Supporting the goals and ideals of International Transgender Day of Visibility; H.R.28 and S.9, Protection of Women and Girls in Sports Act of 2025; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; H.R.21 and S.6, the so-called Born-Alive Abortion Survivors Protection Act; Grants to enhance security and safety for health care providers, including H.R.612, the Health Care Providers Safety Act; Data and health records privacy as it relates to abortion care; Issues related to emergency abortion care, including Idaho v. United States; Issues Medina v. Planned Parenthood South Atlantic (PPSAT) and Medicaids free-choice-of-provider provision; Funding for costs related to traveling for abortion care; Access to evidence-based medication abortion care; Issues related to the Comstock Act, including H.R.2029 and S.951, the Stop Comstock Act; Access to and affordability of contraceptives; Access to contraception and the right to contraception, including H.R.999 and S.422 the Right to Contraception Act; Contraceptive coverage, including H.R.2529 and S.1239, requiring insurers to cover a full year supply of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including H.R.1742, the Access to Reproductive Care for Servicemembers Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including breastfeeding support; S.916 Stop Shackling and Detaining Pregnant Women Act; Paid Family and Medical Leave, including H.R. 1035 and S.408, the Job Protection Act and H.R.1002 and S.437, the Caring for All Families Act; Child tax credit and using the tax code to increase investments in women and families; Foreign aid and investments in international family planning; Gender equity and sex discrimination, including H.R.17 and S.1115, the Paycheck Fairness Act; LGBTQI+ rights; Discrimination against LGBTQI+ people, including the joint resolution H.Con.Res.23 and S.Con.Res.11, Supporting the goals and ideals of International Transgender Day of Visibility; H.R.28 and S.9, Protection of Women and Girls in Sports Act of 2025; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits; Extension of ACA enhanced premium tax credits, including S.3385, the Lower Health Care Costs Act; S.3386, the Health Care Freedom for Patients Act of 2025; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R.5925, the Reproductive and Sexual Health Ombuds Act; Access to evidence-based medication abortion care; The Endometriosis CARE Act (not yet introduced); Veterans access to reproductive health care, including H.R.4876 The Reproductive Freedom for Veterans Act; Healthy pregnancy and post-partum period; Family and medical leave, including paid leave; Gender equity and sex discrimination; Empowering and informing young people about sexual and reproductive health, including gender identity and LGBTQ+ inclusion in sex ed curriculum; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including. S.2907 and H.R. 5483, the Chloe Cole Act, and H.R.3492, the Protect Childrens Innocence Act; Issues related to workplace fairness and gender discrimination.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits; Extension of ACA enhanced premium tax credits, including S.3385, the Lower Health Care Costs Act; S.3386, the Health Care Freedom for Patients Act of 2025; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R.5925, the Reproductive and Sexual Health Ombuds Act; Access to evidence-based medication abortion care; The Endometriosis CARE Act (not yet introduced); Veterans access to reproductive health care, including H.R.4876 The Reproductive Freedom for Veterans Act; Healthy pregnancy and post-partum period; Family and medical leave, including paid leave; Gender equity and sex discrimination; Empowering and informing young people about sexual and reproductive health, including gender identity and LGBTQ+ inclusion in sex ed curriculum; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including. S.2907 and H.R. 5483, the Chloe Cole Act, and H.R.3492, the Protect Childrens Innocence Act; Issues related to workplace fairness and gender discrimination.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; H.R.12 and S.2150, the Women's Health Protection Act of 2025, regarding access to abortion care; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Abortion-coverage restrictions; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services and H.R.589, the FACE Act Repeal Act of 2025; Data and health records privacy as it relates to abortion care, including H.R.3916 and S.2029, the My Body, My Data Act; Issues related to emergency abortion care; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R.4099, Ensuring Womens Right to Reproductive Freedom Act, regarding the right to travel to seek reproductive health care; Access to evidence-based medication abortion care; Access to and affordability of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including the Reproductive Freedom for Veterans Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including Medicaid coverage and access to labor and delivery units; Maternal and child health funding, including Title V and SET-NET; Empowering and informing young people about sexual and reproductive health, including H.R.3527 and S.1910, the Real Education and Access for Healthy Youth Act (REAHYA), which would provide federal funding for comprehensive sex education and H.Res.445 Sex Ed for All Month: Equity and Access for All Resolution; Paid Family and Medical Leave; Continued operation of the Labor Departments Womens Bureau; Continued operation of the Department of Education; Foreign aid and investments in international family planning; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R. 4796 and S.2524, the Restoring Essential Health Care Act; Access to evidence-based medication abortion care; The integrity of and critical services provided by the U.S. Preventive Services Task Force; Access to and affordability of contraceptives; Denials of contraceptive care, including H.R.4084 and S.2302 the Access to Birth Control Act; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including S.2296 and H.R.3838, the FY26 National Defense Authorization Act and H.R.4876 The Reproductive Freedom for Veterans Act; Restrictions or bans on reproductive freedom, gender affirming care, and DEI initiatives in the FY26 National Defense Authorization Act, S.2296 and H.R.3838; Assisted Reproductive Technology, including H.R.4648 and S.2408 the Access to Fertility Treatment and Care Act and H.R.4855 and S.2534 the Veteran Families Health Services Act of 2025; Healthy pregnancy and post-partum period, including Medicaid coverage and access to labor and delivery units; Paid Family and Medical Leave, including H.R.5390 and S.2823 the Family and Medical Insurance Leave (FAMILY) Act; Womens participation in apprenticeship programs; Non-discrimination requirements for federal contractors; Continued operation of the Labor Departments Womens Bureau; Foreign aid and investments in international family planning, including rescissions in H.R.4; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; H.R.12 and S.2150, the Women's Health Protection Act of 2025, regarding access to abortion care; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Abortion-coverage restrictions; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services and H.R.589, the FACE Act Repeal Act of 2025; Data and health records privacy as it relates to abortion care, including H.R.3916 and S.2029, the My Body, My Data Act; Issues related to emergency abortion care; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R.4099, Ensuring Womens Right to Reproductive Freedom Act, regarding the right to travel to seek reproductive health care; Access to evidence-based medication abortion care; Access to and affordability of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including the Reproductive Freedom for Veterans Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including Medicaid coverage and access to labor and delivery units; Maternal and child health funding, including Title V and SET-NET; Empowering and informing young people about sexual and reproductive health, including H.R.3527 and S.1910, the Real Education and Access for Healthy Youth Act (REAHYA), which would provide federal funding for comprehensive sex education and H.Res.445 Sex Ed for All Month: Equity and Access for All Resolution; Paid Family and Medical Leave; Continued operation of the Labor Departments Womens Bureau; Continued operation of the Department of Education; Foreign aid and investments in international family planning; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R. 4796 and S.2524, the Restoring Essential Health Care Act; Access to evidence-based medication abortion care; The integrity of and critical services provided by the U.S. Preventive Services Task Force; Access to and affordability of contraceptives; Denials of contraceptive care, including H.R.4084 and S.2302 the Access to Birth Control Act; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including S.2296 and H.R.3838, the FY26 National Defense Authorization Act and H.R.4876 The Reproductive Freedom for Veterans Act; Restrictions or bans on reproductive freedom, gender affirming care, and DEI initiatives in the FY26 National Defense Authorization Act, S.2296 and H.R.3838; Assisted Reproductive Technology, including H.R.4648 and S.2408 the Access to Fertility Treatment and Care Act and H.R.4855 and S.2534 the Veteran Families Health Services Act of 2025; Healthy pregnancy and post-partum period, including Medicaid coverage and access to labor and delivery units; Paid Family and Medical Leave, including H.R.5390 and S.2823 the Family and Medical Insurance Leave (FAMILY) Act; Womens participation in apprenticeship programs; Non-discrimination requirements for federal contractors; Continued operation of the Labor Departments Womens Bureau; Foreign aid and investments in international family planning, including rescissions in H.R.4; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R. 4796 and S.2524, the Restoring Essential Health Care Act; Access to evidence-based medication abortion care; The integrity of and critical services provided by the U.S. Preventive Services Task Force; Access to and affordability of contraceptives; Denials of contraceptive care, including H.R.4084 and S.2302 the Access to Birth Control Act; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including S.2296 and H.R.3838, the FY26 National Defense Authorization Act and H.R.4876 The Reproductive Freedom for Veterans Act; Restrictions or bans on reproductive freedom, gender affirming care, and DEI initiatives in the FY26 National Defense Authorization Act, S.2296 and H.R.3838; Assisted Reproductive Technology, including H.R.4648 and S.2408 the Access to Fertility Treatment and Care Act and H.R.4855 and S.2534 the Veteran Families Health Services Act of 2025; Healthy pregnancy and post-partum period, including Medicaid coverage and access to labor and delivery units; Paid Family and Medical Leave, including H.R.5390 and S.2823 the Family and Medical Insurance Leave (FAMILY) Act; Womens participation in apprenticeship programs; Non-discrimination requirements for federal contractors; Continued operation of the Labor Departments Womens Bureau; Foreign aid and investments in international family planning, including rescissions in H.R.4; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; H.R.12 and S.2150, the Women's Health Protection Act of 2025, regarding access to abortion care; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Abortion-coverage restrictions; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services and H.R.589, the FACE Act Repeal Act of 2025; Data and health records privacy as it relates to abortion care, including H.R.3916 and S.2029, the My Body, My Data Act; Issues related to emergency abortion care; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R.4099, Ensuring Womens Right to Reproductive Freedom Act, regarding the right to travel to seek reproductive health care; Access to evidence-based medication abortion care; Access to and affordability of contraceptives; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including the Reproductive Freedom for Veterans Act; Assisted Reproductive Technology, including IVF; Healthy pregnancy and post-partum period, including Medicaid coverage and access to labor and delivery units; Maternal and child health funding, including Title V and SET-NET; Empowering and informing young people about sexual and reproductive health, including H.R.3527 and S.1910, the Real Education and Access for Healthy Youth Act (REAHYA), which would provide federal funding for comprehensive sex education and H.Res.445 Sex Ed for All Month: Equity and Access for All Resolution; Paid Family and Medical Leave; Continued operation of the Labor Departments Womens Bureau; Continued operation of the Department of Education; Foreign aid and investments in international family planning; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits; Extension of ACA enhanced premium tax credits, including S.3385, the Lower Health Care Costs Act; S.3386, the Health Care Freedom for Patients Act of 2025; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R.5925, the Reproductive and Sexual Health Ombuds Act; Access to evidence-based medication abortion care; The Endometriosis CARE Act (not yet introduced); Veterans access to reproductive health care, including H.R.4876 The Reproductive Freedom for Veterans Act; Healthy pregnancy and post-partum period; Family and medical leave, including paid leave; Gender equity and sex discrimination; Empowering and informing young people about sexual and reproductive health, including gender identity and LGBTQ+ inclusion in sex ed curriculum; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including. S.2907 and H.R. 5483, the Chloe Cole Act, and H.R.3492, the Protect Childrens Innocence Act; Issues related to workplace fairness and gender discrimination.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R. 4796 and S.2524, the Restoring Essential Health Care Act; Access to evidence-based medication abortion care; The integrity of and critical services provided by the U.S. Preventive Services Task Force; Access to and affordability of contraceptives; Denials of contraceptive care, including H.R.4084 and S.2302 the Access to Birth Control Act; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including S.2296 and H.R.3838, the FY26 National Defense Authorization Act and H.R.4876 The Reproductive Freedom for Veterans Act; Restrictions or bans on reproductive freedom, gender affirming care, and DEI initiatives in the FY26 National Defense Authorization Act, S.2296 and H.R.3838; Assisted Reproductive Technology, including H.R.4648 and S.2408 the Access to Fertility Treatment and Care Act and H.R.4855 and S.2534 the Veteran Families Health Services Act of 2025; Healthy pregnancy and post-partum period, including Medicaid coverage and access to labor and delivery units; Paid Family and Medical Leave, including H.R.5390 and S.2823 the Family and Medical Insurance Leave (FAMILY) Act; Womens participation in apprenticeship programs; Non-discrimination requirements for federal contractors; Continued operation of the Labor Departments Womens Bureau; Foreign aid and investments in international family planning, including rescissions in H.R.4; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits; Extension of ACA enhanced premium tax credits, including S.3385, the Lower Health Care Costs Act; S.3386, the Health Care Freedom for Patients Act of 2025; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R.5925, the Reproductive and Sexual Health Ombuds Act; Access to evidence-based medication abortion care; The Endometriosis CARE Act (not yet introduced); Veterans access to reproductive health care, including H.R.4876 The Reproductive Freedom for Veterans Act; Healthy pregnancy and post-partum period; Family and medical leave, including paid leave; Gender equity and sex discrimination; Empowering and informing young people about sexual and reproductive health, including gender identity and LGBTQ+ inclusion in sex ed curriculum; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including. S.2907 and H.R. 5483, the Chloe Cole Act, and H.R.3492, the Protect Childrens Innocence Act; Issues related to workplace fairness and gender discrimination.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R. 4796 and S.2524, the Restoring Essential Health Care Act; Access to evidence-based medication abortion care; The integrity of and critical services provided by the U.S. Preventive Services Task Force; Access to and affordability of contraceptives; Denials of contraceptive care, including H.R.4084 and S.2302 the Access to Birth Control Act; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including S.2296 and H.R.3838, the FY26 National Defense Authorization Act and H.R.4876 The Reproductive Freedom for Veterans Act; Restrictions or bans on reproductive freedom, gender affirming care, and DEI initiatives in the FY26 National Defense Authorization Act, S.2296 and H.R.3838; Assisted Reproductive Technology, including H.R.4648 and S.2408 the Access to Fertility Treatment and Care Act and H.R.4855 and S.2534 the Veteran Families Health Services Act of 2025; Healthy pregnancy and post-partum period, including Medicaid coverage and access to labor and delivery units; Paid Family and Medical Leave, including H.R.5390 and S.2823 the Family and Medical Insurance Leave (FAMILY) Act; Womens participation in apprenticeship programs; Non-discrimination requirements for federal contractors; Continued operation of the Labor Departments Womens Bureau; Foreign aid and investments in international family planning, including rescissions in H.R.4; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R. 4796 and S.2524, the Restoring Essential Health Care Act; Access to evidence-based medication abortion care; The integrity of and critical services provided by the U.S. Preventive Services Task Force; Access to and affordability of contraceptives; Denials of contraceptive care, including H.R.4084 and S.2302 the Access to Birth Control Act; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including S.2296 and H.R.3838, the FY26 National Defense Authorization Act and H.R.4876 The Reproductive Freedom for Veterans Act; Restrictions or bans on reproductive freedom, gender affirming care, and DEI initiatives in the FY26 National Defense Authorization Act, S.2296 and H.R.3838; Assisted Reproductive Technology, including H.R.4648 and S.2408 the Access to Fertility Treatment and Care Act and H.R.4855 and S.2534 the Veteran Families Health Services Act of 2025; Healthy pregnancy and post-partum period, including Medicaid coverage and access to labor and delivery units; Paid Family and Medical Leave, including H.R.5390 and S.2823 the Family and Medical Insurance Leave (FAMILY) Act; Womens participation in apprenticeship programs; Non-discrimination requirements for federal contractors; Continued operation of the Labor Departments Womens Bureau; Foreign aid and investments in international family planning, including rescissions in H.R.4; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care.

Reproductive healthcare in FY26 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions, including restrictions related to ACA premium tax credits; Issues related to Medicaids free-choice-of-provider provision; Defunding Planned Parenthood; H.R. 4796 and S.2524, the Restoring Essential Health Care Act; Access to evidence-based medication abortion care; The integrity of and critical services provided by the U.S. Preventive Services Task Force; Access to and affordability of contraceptives; Denials of contraceptive care, including H.R.4084 and S.2302 the Access to Birth Control Act; Access to reproductive health services, including contraception and abortion, for veterans, servicemembers, and servicemembers dependents, including S.2296 and H.R.3838, the FY26 National Defense Authorization Act and H.R.4876 The Reproductive Freedom for Veterans Act; Restrictions or bans on reproductive freedom, gender affirming care, and DEI initiatives in the FY26 National Defense Authorization Act, S.2296 and H.R.3838; Assisted Reproductive Technology, including H.R.4648 and S.2408 the Access to Fertility Treatment and Care Act and H.R.4855 and S.2534 the Veteran Families Health Services Act of 2025; Healthy pregnancy and post-partum period, including Medicaid coverage and access to labor and delivery units; Paid Family and Medical Leave, including H.R.5390 and S.2823 the Family and Medical Insurance Leave (FAMILY) Act; Womens participation in apprenticeship programs; Non-discrimination requirements for federal contractors; Continued operation of the Labor Departments Womens Bureau; Foreign aid and investments in international family planning, including rescissions in H.R.4; Gender equity and sex discrimination; LGBTQI+ rights; Discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care.